FDA Delays Effective Date of Nonprescription Drug Rule Until March 2025
January 28, 2025
January 28, 2025
WASHINGTON, Jan. 28 (TNSFR) -- The Food and Drug Administration (FDA) has announced a delay in the effective date of its final rule regarding nonprescription drug products with an additional condition for nonprescription use (ACNU).
Originally scheduled to take effect on January 27, 2025, the rule will now be effective on March 21, 2025, following a directive from President Trump issued on January 20, 2025. The memorandum, titled "Regulatory Freeze Pending Review," mandat . . .
Originally scheduled to take effect on January 27, 2025, the rule will now be effective on March 21, 2025, following a directive from President Trump issued on January 20, 2025. The memorandum, titled "Regulatory Freeze Pending Review," mandat . . .